Waverly Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.06M | Buy |
65,713
+2,195
| +3% | +$236K | 0.08% | 239 |
|
|
2025
Q1 | $6.41M | Buy |
63,518
+52,344
| +468% | +$5.28M | 0.08% | 240 |
|
|
2024
Q4 | $998K | Buy |
11,174
+2,179
| +24% | +$195K | 0.02% | 506 |
|
|
2024
Q3 | $754K | Sell |
8,995
-56
| -0.6% | -$4.69K | 0.01% | 498 |
|
|
2024
Q2 | $697K | Buy |
9,051
+425
| +5% | +$32.7K | 0.01% | 502 |
|
|
2024
Q1 | $591K | Buy |
8,626
+962
| +13% | +$65.9K | 0.01% | 448 |
|
|
2023
Q4 | $443K | Sell |
7,664
-4
| -0.1% | -$231 | 0.02% | 313 |
|
|
2023
Q3 | $405K | Buy |
7,668
+18
| +0.2% | +$950 | 0.02% | 283 |
|
|
2023
Q2 | $414K | Buy |
+7,650
| New | +$414K | 0.02% | 262 |
|
|
2018
Q1 | – | Sell |
-14,412
| Closed | -$357K | – | 206 |
|
|
2017
Q4 | $357K | Buy |
14,412
+4,756
| +49% | +$118K | 0.05% | 178 |
|
|
2017
Q3 | $282K | Buy |
+9,656
| New | +$282K | 0.06% | 184 |
|
|
2014
Q4 | – | Sell |
-310
| Closed | -$4K | – | 457 |
|
|
2014
Q3 | $4K | Hold |
310
| – | – | ﹤0.01% | 652 |
|
|
2014
Q2 | $4K | Buy |
310
+17
| +6% | +$219 | ﹤0.01% | 614 |
|
|
2014
Q1 | $4K | Sell |
293
-146
| -33% | -$1.99K | ﹤0.01% | 579 |
|
|
2013
Q4 | $5K | Buy |
+439
| New | +$5K | ﹤0.01% | 666 |
|